chronic – Talk Bio

Actionable Insights Powered by AI

Novartis Licenses Kyorin’s Preclinical Chronic Hives Drug for $55M Upfront

2 months ago talkbio0Tagged chronic, Dosage Forms, KRP, KRP-M223, Kyorin, MRGPRX2 gene, Novartis

Novartis, Kyorin Pharmaceutical, KRP-M223, chronic spontaneous urticaria, licensing deal, MRGPRX2 antagonist

Novartis Secures Global Rights to Kyorin’s KRP-M223 for Allergic and Inflammatory Diseases

2 months ago talkbio0Tagged Antagonist muscle action, chronic, Dosage Forms, Dupixent, KRP, KRP-M223, Kyorin, licensing agreement, MRGPRX2 gene, Novartis

Novartis, Kyorin Pharmaceutical, KRP-M223, MRGPRX2 antagonist, chronic spontaneous urticaria, Dupixent, licensing agreement

Allakos Announces Discontinuation of AK006 Program and 75% Layoffs Following Clinical Trial Failures

3 months ago talkbio0Tagged AK006, Allakos, chronic, Clinical Trials, Dermatitis, Atopic, Failure (biologic function)

Allakos, AK006, clinical trial failure, layoffs, biotech, chronic spontaneous urticaria, atopic dermatitis

Jasper Therapeutics Escalates Dose in Hives Trial Following Rapid Complete Responses

6 months ago talkbio0Tagged briquilimab, chronic, Clinical Research, Clinical Trials, Dosage, Escalation, SPOTLIGHT, Urticaria

Jasper Therapeutics, briquilimab, chronic inducible urticaria, hives, dose escalation, clinical trial, SPOTLIGHT study